AUTHORS
Karen Fang, MS, Dakai Ling2, Tamás Füzesi, PhD3, Yongran Yan4, Rose Hurren5, Andrea Arruda6, Maria Perusini, MD, Msc7, Li Zhang, MD, PhD8, Minna Woo, MD, PhD9, Jaideep Bains, PhD10, Aaron Schimmer, MD PhD11
AFFILIATIONS
1 Princess Margaret Cancer Centre, Toronto, Ontario, Canada, University of Toronto, Toronto, Ontario, Canada
2 Princess Margaret Cancer Centre, Toronto, Ontario, Canada
3 Krembil Brain Institute, Toronto, Ontario, Canada
4 Princess Margaret Cancer Centre, Toronto, Ontario, Canada
5 Princess Margaret Cancer Centre, Toronto, Ontario, Canada
6 Princess Margaret Cancer Centre, Toronto, Ontario, Canada
7 Princess Margaret Cancer Centre, Toronto, Ontario, Canada
8 Toronto General Hospital Research Institute, Toronto, Ontario, Canada
9 Toronto General Hospital Research Institute, Toronto, Ontario, Canada
10 Krembil Brain Institute, Toronto, Ontario, Canada
11 Princess Margaret Cancer Centre, Toronto, Ontario, Canada
ABSTRACT
The hypothalamic-pituitary-adrenal (HPA) axis is a major neuroendocrine pathway that can be activated by psychological and physiological stress. The neuroendocrine stress response is increasingly recognized for its role in promoting the progression of solid tumors. However, its effect on hematologic malignancies remains poorly understood. In this study, we examined the impact of activating the HPA axis by psychological and physiological stress on the progression of B-cell malignancies.
Surprisingly, and in contrast to studies in solid tumor models, daily mild psychological stressors, including predator odor, noise, and tilted cages, reduced B-cell lymphoma growth in both male and female immunocompetent BALB/c mice (72% decrease in tumor volume, p<0.0001). To determine whether this effect was dependent on the adaptive immune system, we performed these experiments in immunodeficient SCID and NSG mouse models engrafted with B-cell leukemia/lymphoma. The tumor-suppressive effect of stress was consistently observed across these models (p=0.003), suggesting an immune-independent mechanism. Importantly, the tumor-suppressive effect of stress was lineage-specific, as identical stressors did not affect the growth of murine or human myeloid malignancies in vivo. Notably, these stressors did not impact animal body weight or the number and function of splenic T, B, and NK cells.
Mechanistically, stress induced a transient 2.2-fold increase in serum corticosterone levels that lasted less than 2 hours as measured by enzyme-linked immunosorbent assays (ELISA) (p<0.0008). In vitro proliferation assays demonstrated that stress-relevant concentrations of corticosterone suppressed the proliferation of B-cell leukemia/lymphoma cells. Knockdown of the glucocorticoid receptor in lymphoma cells abrogated stress-induced suppression of lymphoma growth in vivo, indicating that the antileukemic effect of stress was mediated by glucocorticoid signaling.
To translate these findings into a clinically implementable, non-pharmacological strategy, we evaluated whether activating the HPA axis with exercise could recapitulate the antileukemic effect of stress. High-intensity exercise is a physiological stressor known to activate the HPA axis and elevate serum glucocorticoid levels in mouse models and humans. We subjected mice xenografted with B-cell leukemia/lymphoma cells to daily 30-minute treadmill high-intensity exercise regimens. Compared to the sedentary controls, high-intensity exercise significantly delayed tumor progression (56% decrease in tumor volume, p=0.0003) and transiently triggered a 1.7-fold increase in serum corticosterone levels (p=0.0015) that lasted less than 2 hours. Conversely, exercise for the same duration but with lower intensity, did not affect tumor progression or serum corticosterone levels. Similar to the stress cohorts, high-intensity exercise suppressed tumor growth without impacting animal body weight or the number or function of splenic immune cells. Finally, knockdown of the glucocorticoid receptor in B-cell leukemia/lymphoma cells completely abolished the tumor suppression induced by high-intensity exercise.
In summary, we discovered that activating the HPA axis via stress or high-intensity exercise suppressed B-cell leukemia/lymphoma growth via the glucocorticoid signaling pathway. These results challenge the prevailing view that stress is universally pro-tumorigenic and highlight the need to consider tissue- and lineage-specific effects of neuroendocrine regulation. Further, our findings highlight the potential of high-intensity exercise as a therapeutic strategy to harness the antileukemic effect of HPA axis activation and prevent relapse in patients with B-cell malignancies.
DISCLOSURES
Karen Fang, MS: No relevant conflicts of interest to declare.